3,606
Views
7
CrossRef citations to date
0
Altmetric
Coronavirus – Review

Models of determinants of COVID-19 vaccine hesitancy in non-pregnant and pregnant population: Review of current literature”

, &
Article: 2138047 | Received 06 Jun 2022, Accepted 15 Oct 2022, Published online: 07 Nov 2022

ABSTRACT

Vaccination has proven to be the most effective tool in controlling the COVID-19 pandemic. While pregnant individuals are considered to be a high-risk population and are more likely to experience adverse effects from COVID-19, vaccination rates among pregnant individuals are significantly lower than in the general population. The Health Belief Model (HBM), Theory of Planned Behavior (TPB), 3C model, 5C model, and 5A model have been used to assess vaccination hesitancy behaviors. In this paper, we review the use of each of these models to address vaccine hesitancy, with a focus on the pregnant population and the COVID-19 vaccine. The HBM, TPB, 3C model, and 5C model have demonstrated great versatility in their ability to evaluate, explain, and modify vaccine hesitancy and behavior. Up to date, the HBM and 3C models appear to be the most effective models to study and address vaccination hesitancy within the pregnant persons.

This article is part of the following collections:
The landscape of Covid-19 vaccines: development, deployment, acceptance

Introduction

As the impact of the COVID-19 pandemic continues to evolve, it has become clear that our greatest tool in controlling the virus is vaccination. Fully vaccinated individuals have a decreased risk of contracting COVID-19, and if they do become infected, the risk of severe illness and hospitalization is substantially reduced.Citation1 This is especially relevant for at-risk groups such as pregnant persons. Research has shown that pregnant persons diagnosed with COVID-19 are more likely to have higher maternal morbidity and mortality, including higher rates of preeclampsia, preterm birth, and maternal mortality.Citation2 Additionally, newborns of persons with COVID-19 have significantly higher severe perinatal morbidity and mortality compared with newborns of persons without a COVID-19 diagnosis.Citation2 Pregnant persons who were vaccinated against COVID-19 infection had a reduction in severe COVID-19 infection, if they got infected, and reduction in perinatal death, and in COVID-19-related hospitalization among infants of up to 6 months of age.Citation3–7 According to the CDC, as of May 2022, over 205,000 pregnant persons were diagnosed with COVID-19, over 32,000 were hospitalized, and over 290 died from complications due to COVID-19.Citation8 However, vaccination of this population remains low—only 69.5% of the pregnant persons are fully vaccinated.Citation8 Additionally, Black pregnant persons, who have some of the highest rates of maternal and fetal morbidity and mortality,Citation9 are the least protected, with only 54.2% fully vaccinated against COVID-19.Citation1 Similar findings were seen in countries outside the US, with over 90% of COVID-19 infection-related hospitalizations and 98% of critical care admissions occurring in unvaccinated pregnant persons.Citation10,Citation11

The importance of understanding vaccination behavior and vaccine hesitancy, defined as delay in acceptance or refusal of vaccination despite the availability of vaccination services,Citation12 has become more important now than ever. Various models have been used to assess vaccine hesitancy including the Health Belief Model, Theory of Planned Behavior, the 3C model, and

more.Citation12–15 The aim of this paper is to review models that have been applied to research addressing vaccine hesitancy, with a focus on pregnant persons.

Models to address vaccine hesitancy

1. Health belief model

The Health Belief Model (HBM) () is one of the most widely employed theories to understand health behaviors and how they correlate with preventive behaviors.Citation13 In its original form, the model aimed to explain the health behaviors of people failing to undergo screening tests for early detection of disease, as well as, the failure of people to take preventative measures such as vaccinations against disease.Citation13 Since its creation, the model has been revised and expanded to include behavioral responses to health-related conditions and more fully explain conceptual relationships.Citation16 The model assumes a perception that an adverse health condition can be avoided, that by following advice an adverse health condition can be averted, and that individuals are able to be convinced to adhere to a recommended behavior.Citation17 The HBM also assumes that existing beliefs can predict future behaviors. When applied to disease prevention, it suggests that a future behavior can be predicted by the combination of an individual’s willingness to prevent an illness and their expectations of a specific action.Citation13

Figure 1. The “Health Belief Model.” Figure reproduced from Rosenstock, Health Education Monographs, 1974.Citation13 Model details the individual perceptions and modifying factors that influence the likelihood of action regarding vaccination behaviors.

Figure 1. The “Health Belief Model.” Figure reproduced from Rosenstock, Health Education Monographs, 1974.Citation13 Model details the individual perceptions and modifying factors that influence the likelihood of action regarding vaccination behaviors.

The HBM is composed of six constructs: perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cues to action, and self-efficacy. Perceived susceptibility refers to an individual’s belief about their vulnerability to infection, i.e., the risk of acquiring COVID-19 infection. There is a wide variation in a person’s feelings of personal vulnerability to COVID-19 infection. Perceived severity refers to and individual’s belief that a disease is dangerous and has serious consequences. There is a wide variation in a person’s feelings of severity, and often a person considers the medical consequences (e.g., death and disability) and social consequences (e.g., family life and social relationships) when evaluating the severity of the possible COVID-19 infection on their life. Perceived benefits refer to an individual’s belief about the usefulness of a behavior and its ability to decrease the risk of severity of an adverse health outcome. The course of action a person takes in order to prevent COVID-19 infection is based on consideration and evaluation of perceived benefits of the COVID-19 vaccine. Perceived barriers refer to an individual’s belief about obstacles that may prevent individuals from performing a health behavior. In the case of COVID-19 vaccination, persons would weigh the effectiveness and safety of the vaccine, and the logistics, convenience, or discomfort of getting vaccinated. Cues to action refer to factors that may influence a behavior change. These factors may include information, people (obstetric provider recommending the vaccine), news (reading a new study about COVID-19 vaccination or COVID-19 illness in pregnancy), or events (friend of a family member getting severe COVID-19 infection). Self-efficacy refers to an individual’s trust in their ability to enact change and successfully perform the health behavior, in this case, vaccination against COVID-19.Citation18–20 For change to be enacted, individuals must feel motivated to make change based off their perceived susceptibility/severity of the health treatment, their positive interactions with cues to action, and the benefits must outweigh the barriers.

Use of the HBM to promote vaccine uptake in non-pregnant individuals

The utility of the HBM in addressing vaccine hesitancy has been validated in diverse patient populations, vaccine types, countries, and modalities.Citation16–18 The HBM has evaluated vaccine hesitancy in many subjects, including patients, physicians, and parents. In a study evaluating physician attitudes, HBM was used to evaluate physician likelihood of recommending vaccinations.Citation21 It has also been used to assess pharmacists’ and other health-care workers’ vaccine acceptance and hesitancy.Citation22–26 Studies have used the HBM to assess parent attitudes toward childhood vaccinations.Citation27–32 Globally, the HBM has been used to assess general vaccine hesitancy in Nigeria,Citation33 the United States,Citation29 and Korea;Citation30 measles and rubella vaccines in Romania and Japan;Citation27,Citation34 shingles vaccines in the United Kingdom;Citation35 influenza vaccines in the United States,Citation36–39 Japan,Citation27 and Australia;Citation40 human papilloma virus vaccines in the United States;Citation28,Citation31,Citation41–48 and COVID-19 vaccines in the United States,Citation21,Citation44–46 China,Citation47–53 Bangladesh,Citation54–56 Turkey,Citation22 Canada,Citation23 Vietnam,Citation57 France,Citation58 Saudi Arabia,Citation59 and Pakistan.Citation60 Several other studies applied HBM to create interventions to increase vaccine knowledge and uptake,Citation16 and to create new scales of vaccine attitudes and intentions to assess the effectiveness of health campaigns and advertising.Citation21,Citation30,Citation31

Use of the HBM in pregnant individuals

The HBM has been applied to several studies investigating predictors of maternal vaccination to influenza,Citation61 COVID-19,Citation61 pertussis,Citation62–65 Hepatitis B,Citation66 Zika,Citation67 Tdap,Citation65,Citation68 and H1N1.Citation69,Citation70 It was found that mothers were more likely to receive vaccinations in order to provide their newborn immunity and due to the provision of antibodies.Citation49 Recommendation of vaccination from a provider was the most influential factor in increasing vaccination.Citation71 When assessing the barriers to vaccination, pregnant individuals who believed that seasonal vaccination was not safe during pregnancy or not effective in protecting their fetus had lower levels of vaccine acceptance for both the influenza and pertussis vaccines.Citation47,Citation62 In addition, gestational age was identified as an important predictor of maternal vaccination and testing.Citation64

Use of the HBM in COVID-19 vaccination uptake in non-pregnant individuals

The HBM has been used to study COVID-19 vaccination attitudes in a variety of populations. While it has been used to study the attitudes of the general population in a multitude of countries,Citation46,Citation53,Citation54,Citation58,Citation59,Citation72 it has also been used to evaluate various subpopulations. The most common subpopulation that has been evaluated has been health-care workers. Several studies have sought to identify and understand the beliefs of physicians, pharmacists, nurses, and health-care workers in general, in both their intent to get vaccinated themselves and their intent to recommend vaccination to others.Citation22–26 One study compared health-care workers to different occupational groups of varying occupational risk of COVID-19 infection as classified by public health officials, and found that health-care workers (the high-risk group) had significantly higher scores for cue to action and lower scores for perceived barriers compared to the other groups.Citation73 Another study compared the general population to health-care workers and found that health-care workers perceived significantly higher susceptibility and severity of the COVID-19 infection compared to the general population.Citation26 In addition to health-care workers, the HBM has also been used to evaluate cultural and racial subgroups,Citation45 health science students,Citation57 and mothers.Citation50,Citation74 Between primarily African American and Latinx subgroups, mistrust, fear, and lack of information were the main themes regarding COVID-19 vaccine hesitancy.Citation45 These themes were then contextualized within the HBM constructs in which mistrust was identified with perceived barriers, fear was identified with perceived susceptibility and severity, and lack of information was identified with perceived severity and barriers.Citation41 In a study assessing health science students, vaccine intention was significantly related to perceived susceptibility, perceived severity, benefits of vaccination, and cues to action.Citation53 In the studies exploring non-pregnant mothers’ willingness to vaccinate their children, hesitancy was found to be associated with decreased perceived susceptibility, benefit, and severity as well as increased perceived barriers.Citation39 It was also found that previous vaccine behaviors and attitudes did not fully predict a mother’s willingness to vaccinate their children for COVID-19.Citation71 The most commonly identified barrier to COVID-19 vaccination noted in the literature was concern for side effects or adverse effects.Citation24,Citation26,Citation51,Citation72,Citation73 Concerns about vaccine safety and effectiveness were also noted as barriers in multiple studies.Citation24,Citation26,Citation51,Citation73 The most notable cues to action related to recommendation of the vaccine from the leading authorities or trustworthy individuals including the government,Citation72,Citation73 media,Citation26,Citation55,Citation73 medical experts,Citation26,Citation73 and the World Health Organization.Citation26

In the employment of the HBM in COVID-19 vaccination uptake, the model was used to hypothesize effective strategies to overcome vaccination hesitancy and influence behavioral change interventions.Citation46 A study evaluating the ability of communication strategies to modify COVID-19 vaccination hesitancy suggested that willingness to be vaccinated is influenced by the media and public service messages, especially emotionally- and fear-centered public service messages.Citation60 Multiple studies in which participants demonstrated a low level of perceived susceptibility to COVID-19 recommended efforts to enhance public education of the probability of outbreak resurgence and the real susceptibility to COVID-19.Citation46,Citation50,Citation52,Citation53 Another study highlighted the importance of physicians in the cue-to-action role and recommended that physicians promote vaccination uptake in targeted campaigns.Citation54 Overall, the studies recommended that the HBM constructs may be used to develop targeted communication campaigns to increase vaccine behaviors.

Use of the HBM in COVID-19 vaccination uptake in pregnant individuals

The HBM has been explored in COVID-19 vaccine acceptance among pregnant Chinese individuals.Citation48 Higher acceptance was associated with high knowledge score on COVID-19, high level of perceived susceptibility, low level of perceived barriers to vaccination, high level of perceived benefit, and high level of perceived cues to action.Citation48 Individual’s reasoning for declining COVID-19 vaccination included concerns about side effects, safety, and efficacy of the COVID-19 vaccination both for themselves and their unborn child. This information was used to influence efforts to increase vaccination rates among the pregnant population.Citation48 A recent study examined the performance of HBM among pregnant individuals in Iran found that perceived benefits and cues to action components of HBM had significant effects on vaccine hesitancy, while the perceived threat component has no significant effect on it.Citation75

Performance of the HBM with annual vaccines versus vaccines given once or twice

The HBM has been used to explore vaccine attitudes about vaccinations with various schedules. The model has been used to assess annual vaccinations;Citation36,Citation40 vaccinations given a few times, such as the human papillomavirus vaccination;Citation28,Citation41 and the childhood vaccination schedule.Citation29,Citation32 While most studies analyze the behaviors of one method of vaccination schedule, a study in Japan explored attitudes toward both influenza and rubella vaccination in tandem.Citation27 This study employed constructs of the HBM to assess how receiving risk information and advice from peers and family members influences individuals’ decision-making regarding vaccines. Regarding rubella vaccination, susceptibility information and minor risk information led to the greatest increase in intent to be vaccinated, while severe risk information decreased intent. Likewise, intent to receive influenza vaccination increased after participants were provided minor risk information, susceptibility information, and peer advice.Citation27

The HBM has been used to explore vaccination beliefs about a variety of vaccinations that are given a few times. This includes but is not limited to measles,Citation34 human papillomavirus,Citation28,Citation31,Citation41–43 and shingles.Citation35 Similar to its use in the COVID-19 literature, the HBM has been used to examine behaviors and attitudes that make an individual more or less likely to accept the HPV vaccine.Citation28,Citation41,Citation42 These studies were able to identify the trend of social media content related to HPV vaccinations and the presence of HBM constructs within the content to inform efforts to improve vaccine understanding and intent.

The HBM has also been used to evaluate vaccine hesitancy in relation to annual vaccinations, such as influenza. As with all other vaccinations, the model has been used to predict and assess vaccine hesitancy and acceptance behaviors in addition to identifying barriers. Tweets from the 2018–2019 influenza season were also analyzed based on their inclusion of HBM constructs, similar to the social media analysis of the HPV vaccination. Interestingly, tweets in the early flu season were more likely to discuss vaccine uptake self-efficacy, while tweets in the peak flu season were more likely to mention susceptibility to the flu and barriers to vaccination.Citation38

2. Theory of planned behavior model

The Theory of Planned Behavior (TPB) () is built upon the belief that an individual’s decision to engage in a behavior can be predicted by their intention to engage in that behavior.Citation14 The theory suggests that attitudes, subjective norms, and perceived behavioral control predict an individual’s intention to engage in a health behavior.Citation76 In succession, the intention to engage in a healthy behavior is the best predictor of an individual performing said behavior.Citation14,Citation77 The theory depends upon the assumption that people have the ability to practice self-control when moderating their behavior.Citation14

Figure 2. Theory of Planned Behavior. Figure reproduced from Ajzen, Organizational Behavior and Human Decision Processes, 1991.Citation14 Figure details the relationship between various constructs and their ability to influence vaccination intention and overall behavior.

Figure 2. Theory of Planned Behavior. Figure reproduced from Ajzen, Organizational Behavior and Human Decision Processes, 1991.Citation14 Figure details the relationship between various constructs and their ability to influence vaccination intention and overall behavior.

The TPB relies on three constructs: attitudes, subjective norms, and perceived behavioral control. Attitudes refer to an individual’s assessment of the favorableness of an action including its necessity, benefit, and effectiveness.Citation78,Citation79 Subjective norms refer to an individual’s measure of perceived social pressure to perform a behavior based on the opinion of others and how much value one places in other’s opinions.Citation76 This construct may include family, friends, health-care professionals, social media, and mainstream media.Citation78 Perceived behavioral control refers to an individual’s perception of their capability of performing a given behavior. Perceived behavioral control is a combination of both perceived control and self-efficacy and has both a direct and an indirect effect on behavior, through its effects on intentions.Citation80,Citation81 Altogether, the TPB assumes a positive correlation between an individual’s attitudes, social norms, and perceived behavior control and increased intention to perform a behavior, which in turn, results in greater health behavior performance.Citation14,Citation77

Use of the TPB to promote vaccine uptake in non-pregnant individuals

The TPB has been used as a tool to assess vaccine hesitancy in a multitude of vaccinations globally. The TPB has been used to evaluate general and childhood vaccine hesitancy in Italy,Citation82 China,Citation83 Canada,Citation84 and the United States;Citation85 influenza vaccination in the United States;Citation74,Citation86–88 HPV vaccination in the United States;Citation41,Citation89 Hepatitis B vaccination in Uganda;Citation66 Swine Flu vaccination in the United Kingdom;Citation90 the Boostrix-IPV vaccination in the United Kingdom;Citation91 and COVID-19 vaccination in the United States,Citation46,Citation92 Bangladesh,Citation54–56 Ireland,Citation93 New Zealand,Citation94 Pakistan,Citation95 and Malta.Citation96 While this list is not conclusive, it begins to illustrate the versatility and usability of the TPB.

In addition to informing and structuring study questionnaires, the TPB has been utilized diversely. It has provided the foundation for a behavioral analysis approach to examining vaccination acceptance and guided the development of research questions to evaluate vaccination behavior.Citation56,Citation97 In addition, the TPB has been used to develop interview questions for studies, including one study that used motivational interviewing techniques in attempts to decrease vaccine hesitancy.Citation98 The TPB has also been used as a guide for literature reviews exploring vaccination intention.Citation85

Use of the TPB model in pregnant individuals

The TPB has been used to assess pregnant individual’s vaccine intention and behaviors.Citation66,Citation71,Citation90,Citation91 In a literature review that explored predictors of maternal vaccination, the TPB model was used in eight of twelve reviewed studies that were theoretically based.Citation71 The model is used to explore pregnant individual’s beliefs about the Boostrix-IPV,Citation91 influenza,Citation76 hepatitis B,Citation66 and swine flu vaccinations.Citation90

Repeatedly in the literature, the TPB is found to be a validated measure of pregnant individual’s intentions to get vaccinated. In a study exploring women’s hesitancy about the Boostrix-IPV vaccination, the TPB predicted 86% of the variance in vaccine intentions, with subjective norms and attitudes being the best predictors. In regard to vaccine behavior, the model accounted for 36% of the variance.Citation91 In another study, which evaluated pregnant individual’s intent to receive the swine flu vaccination, the TPB explained 66% of the variance in intention to be vaccinated. In this study, attitude, subjective norm, and perceived control were all found to be predicative of vaccination intention.Citation90

While the TPB has been found to be predictive of vaccination intention in pregnant individuals, multiple studies have expressed concerns about the model. One study highlighted that the theory was better at predicting vaccination intent than vaccination behavior and emphasized that public health interventions are more commonly built upon vaccination behavior.Citation91 This same study also highlighted that the TPB does not account for all variables contributing to vaccine behavior and suggested that further work may need to be done to explore these variables.Citation91

Use of the TPB model in COVID-19 vaccination uptake in non-pregnant individuals

Within the literature that explores the TPB and COVID-19, the relationship is bidirectional. The literature supports that the TPB is a validated measure to explore COVID-19 vaccine hesitancy.Citation93 Conversely, the literature also supports that attitudes and behaviors toward the COVID-19 vaccine support the TPB.Citation96 In multiple studies, attitudes, subjective norms, and perceived behavioral control were found to have a significant impact on vaccination intent and behavior.Citation93–95 In one study, the constructs of the TPB accounted for 74% of variance in COVID-19 vaccination intention.Citation95 In a study that evaluated multiple assessments of vaccination hesitancy, the TPB was found to have the highest predictive power of COVID-19 vaccination hesitancy.Citation55

The authors suggested that the constructs of the TPB may be beneficial in the development of COVID-19 vaccination public health messages and efforts to improve vaccination uptake.Citation46,Citation93 While the TPB has been used to assess vaccination hesitancy, the application of TPB in promoting COVID-19 vaccine acceptance and uptake has not been tested.

Use of the TPB model in COVID-19 vaccination uptake in pregnant individuals

The use of the TPB model to address COVID-19 vaccine hesitancy and acceptance among pregnant individuals has not been investigated to-date in this review.

Performance of the TPB model with annual vaccines versus vaccines given once or twice

The TPB has been used to assess vaccination hesitancy related to vaccines given at various intervals, including both annuals and vaccines that are given a few times. While most studies analyze one type of vaccine schedule, one study analyzed both annual vaccinations and vaccines that are given once or twice. This study focused on the subjective norm construct from the TPB and found that subjective norms were associated with vaccination intention.Citation97

For vaccines that are given on a few occasions, the TPB has been used to investigate vaccine hesitancy about the human papillomavirus vaccine.Citation41,Citation89 Both attitudes and subjective norms were found to be predictive of vaccination behavior.Citation89 One study addressed how the constructs of TPB and behavioral intentions may vary based on patient knowledge regarding the HPV vaccination. The authors found that different types of knowledge about HPV and the vaccine (genders affected, HPV manifestations, vaccine efficacy, etc.) have different associations with the TPB constructs and ultimately the intention to be vaccinated.Citation89 The other study exploring the TPB and HPV evaluated social media discussions in relation to the vaccination. The attitude construct from TPB was used to analyze social media posts and discussions and observe trends about the vaccination.Citation41

The TPB has also been used to evaluate vaccination hesitancy for vaccines given annually, specifically the influenza vaccination. Attitude and subjective norms have both been found to be significant predictors of an individual’s intention to receive the influenza vaccination.Citation87 In this study, a doctor’s influence was the strongest subjective norm identified.Citation87 In a study that assessed barriers to receiving the influenza vaccination, the negative attitudes (a TPB construct) were amongst the most frequently reported barriers.Citation88 The perception that receiving the influenza vaccination was not the norm in a peer group was also a frequently reported barrier.Citation88

3. The 3C model

In 2012, the Strategic Advisory Group of Experts on Immunization (SAGE) established the SAGE Working Group on Vaccine Hesitancy in response to the globally low levels of vaccine uptake and the negative impacts of vaccine hesitancy.Citation12 The group was tasked with establishing a definition for vaccine hesitancy as well as a working model of determinants. The Working Group created a model to explain the factors influencing vaccine hesitant behavior ().Citation99 The first model, the Working Group Matrix, is more comprehensive and better able to capture the complex factors influencing vaccine behavior. This model groups determinants of vaccine hesitancy into three categories: Contextual influences, Individual and Group influences, and Vaccine/Vaccination specific issues. This matrix was determined to be comprehensive as a systemic review of studies on vaccine hesitancy, and a survey of immunization managers found no other determinants.Citation99,Citation100

Figure 3. SAGE Working Group Matrix of Vaccine Hesitancy. Figure reproduced from Larson, Jarrett, Eckersberger, Smith, and Paterson, Vaccine, 2014.Citation99 Figure demonstrates the determinants of vaccine hesitancy as laid out by the SAGE Working Group.

Figure 3. SAGE Working Group Matrix of Vaccine Hesitancy. Figure reproduced from Larson, Jarrett, Eckersberger, Smith, and Paterson, Vaccine, 2014.Citation99 Figure demonstrates the determinants of vaccine hesitancy as laid out by the SAGE Working Group.

Subsequently, the group simplified the model for practical use and named it the 3C model, after Complacency, Convenience, and Confidence, the three factors most substantially contributing to vaccine behavior ().Citation12 Complacency is present when “perceived risks of vaccine-preventable diseases are low and therefore vaccination is not deemed a necessary preventative action.”Citation12 Convenience measures the degree to which an individual’s ability to obtain vaccines is affected by “physical availability, affordability and willingness-to-pay, geographical accessibility, ability to understand (language and health literacy) and appeal of immunization service affect uptake.”Citation12 Ineffective or inconvenient delivery of vaccination services was associated with increased vaccine hesitancy. Confidence is defined as “trust in (i) the effectiveness and safety of vaccines, (ii) the system that delivers them, including the reliability and competence of the health services and health professionals, and (iii) the motivations of policy-makers who decide on the need of vaccines.”Citation5 Confidence is associated with low levels of vaccine hesitancy.

Figure 4. 3C model. Figure reproduced from the World Health Organization’s SAGE vaccine hesitancy Working Group, Report of the SAGE working group on vaccine hesitancy, 2014.Citation12 Figure demonstrates the factors that contribute to the 3C model.

Figure 4. 3C model. Figure reproduced from the World Health Organization’s SAGE vaccine hesitancy Working Group, Report of the SAGE working group on vaccine hesitancy, 2014.Citation12 Figure demonstrates the factors that contribute to the 3C model.

With both models, the Working Group noted that vaccine hesitancy is complex and can vary depending on the contextual time and place.Citation12,Citation101 Additionally, while these models provide a framework through which to view vaccine behavior, there is no specific measure associated with the 3C model or the Working Group Matrix-outside of a metric for parental vaccine hesitancy.

Use of the 3C model to promote vaccine uptake in non-pregnant individuals

The establishment of the 3C model and the Working Group Matrix have been beneficial for interpreting vaccination intention and behavior. Application of the 3C model has also been used to better understand vaccine hesitancy globally and to formulate interventions aimed at targeting various aspects of confidence, complacency, and/or convenience. Research has applied this model to better understand hesitancy in measles vaccines,Citation102,Citation103 among health-care workers and students,Citation104–107 as well as for general childhood vaccination in Tajikistan.Citation108 There has also been research using the 3C model to create and analyze vaccine hesitancy interventions.Citation109,Citation110

A large systematic review of the 3C model use in vaccine hesitancy found that safety concerns, questions about vaccine effectiveness, and distrust in health-care authorities accounted for a large part of vaccine hesitancy reported throughout the literature, indicating that low levels of confidence likely play a significant role in vaccine behavior.Citation88 A narrative review of vaccine hesitancy among health-care workers found similar trends in vaccine hesitancy as in the general population- low confidence and high complacency led to higher levels of hesitancy.Citation111 Health-care workers with high hesitancy were less likely to be vaccinated and less likely to recommend vaccines to patients, highlighting the importance of decreasing vaccine hesitancy not only within patient populations, but the health-care system as well.Citation111

Use of the 3C model in pregnant individuals

Systematic reviews of vaccine hesitancy within the pregnant and lactating population found that low vaccine confidence was a major barrier to receiving recommended vaccinations during pregnancy, with convenience playing a very limited role in attitudes toward vaccination.Citation112,Citation113 However, as highlighted in one of the reviews, the majority of research included in the reviews came from Western, high-income countries and may not be applicable globally.Citation112

A qualitative study of high-risk groups in South America found that, across the board, low levels of vaccine confidence were a major contributor to vaccine hesitancy.Citation114 However, in pregnant women, complacency also played a significant role. They found that many pregnant women did not consider themselves to be in a “high risk” group that contributed to complacency. A qualitative study of pregnant women’s perception of the Hepatitis B vaccine in Uganda found similar results.Citation115 While low levels of confidence in health-care workers contributed to vaccine hesitancy, complacency due to limited knowledge of Hepatitis B also played a role.

The importance of geographical and cultural context when using the 3C model to understand vaccine hesitancy is highlighted here and emphasizes the need for more research into populations outside of the Western countries.

Use of the 3C model in COVID-19 vaccination uptake in non-pregnant individuals

The 3C model has also been used to a greater degree more recently in understanding COVID-19 vaccine attitudes. As with other vaccines, research has shown that low levels of confidence and convenience, and high levels of complacency, are associated with higher rates of COVID-19 vaccine hesitancy.Citation116–120

While most of the studies on COVID-19 vaccine hesitancy used questionnaires to passively assess vaccine hesitancy,Citation116–120 an experimental study in France found that they could decrease levels of complacency, and subsequently decrease levels of vaccine hesitancy, in the working age population by providing participants with information on herd immunity.Citation21 Another study, looking at COVID-19,Citation121*** explored the underpinnings of low confidence in health-care systems.Citation122 Through their research, they found that health-care literacy was a key mediator in the relationship between health care distrust and vaccine hesitancy. Literature using the 3C model has also examined sociodemographic variations in COVID-19 vaccine hesitancy.Citation123 Hesitancy due to low confidence and higher levels of circumspection (this study’s expansion on convenience) were primarily found in Black respondents- particularly in Black women who were found to have the highest rates of vaccine hesitancy of any group. However, this study also found that hesitancy among Black respondents declined faster than in other groups. While research into the COVID-19 vaccine has been rapidly carried out, as noted by the SAGE working group, vaccine hesitancy is complex. More research is needed in this area to better understand the needs of specific populations, such as pregnant and lactating individuals.

Use of the 3C model in COVID-19 vaccination uptake in pregnant individuals

Studies applying the 3C model to investigate COVID-19 vaccine acceptance among pregnant individuals have not been done to date of this review. However, research into COVID-19 vaccine hesitancy in the pregnant population has identified confidence in the vaccine as a key feature in vaccine acceptance in the US and UK.Citation124,Citation125

Performance of the 3C model with annual vaccines versus vaccines given once or twice

Research using the 3C model to compare general vaccine hesitancy to influenza-specific vaccine hesitancy found that one could not necessarily be substituted for the other.Citation126 Looking at vaccination attitudes and behaviors of US adults, they found that high confidence and convenience and low complacency were associated with lower general vaccine hesitancy. High confidence in the flu-specific vaccine was associated with lower flu vaccine hesitancy and positively associated with rates of flu vaccination in the past year. However, higher general vaccine confidence was not associated with receiving the influenza vaccine for that given year, suggesting that general vaccine hesitancy or acceptance may be specific and unique to specific vaccines. Additional research into nursing home staff and influenza vaccinations suggest that the variability of influenza strains and misconceptions about the possible severity of infection can lead to low confidence and high complacency specific to this vaccine.Citation105 These findings highlight the need for vaccine-specific analysis when utilizing this model.

4. The 5C model

The 5C model of vaccine hesitancy, proposed in 2018, expands the SAGE WHO’s 3C model to add Calculation and Collective Responsibility factors ().Citation127 The 5C model looks at psychological antecedents as a way to better understand an individual’s behavior, “going beyond confidence.”Citation8 Calculation refers to information searching. Individuals engaging in information searching typically do so to conduct their own risk-benefit analysis and are assumed to be more risk averse. Due to the wide availability of vaccine misinformation, individuals with high levels of calculation have positive correlations with perceived vaccination risks and vaccine hesitancy.Citation15 The calculation factor was added to the 3C model as a way to capture an individual’s motivation for thinking about and questioning vaccines.Citation128 Collective responsibility is considered an individual’s “willingness to protect others by one’s own vaccination by means of herd immunity.”Citation8 Individuals with high levels of collective responsibility will have higher levels of collectivism, communal orientation, and empathy. Those who have low levels of collective responsibility, either due to a lack of knowledge about herd immunity or unwillingness to protect others, will have positive correlations with vaccine hesitancy.

Figure 5. The 5C Model. Figure reproduced from Turner, Larson, Dubé, and Fisher, Journal of Allergy and Clinical Immunology: In Practice, 2021.Citation127 Figure details the five factors of the 5C model and the various elements that contribute to their composition.

Figure 5. The 5C Model. Figure reproduced from Turner, Larson, Dubé, and Fisher, Journal of Allergy and Clinical Immunology: In Practice, 2021.Citation127 Figure details the five factors of the 5C model and the various elements that contribute to their composition.

The five factors uniquely interact in every individual to create a psychological state somewhere along the vaccine hesitancy spectrum. The authors of this model note that “the 5C antecedents provide insights in the individual, psychological antecedents and are not suitable to identify systems-related factors–beyond the effect they have on mental representations.”Citation15 For example, low levels of confidence in one individual may be the result of their social environment, whereas for an individual in another country, it may be the result of mistrust in their health-care system. Therefore, the benefit of analyzing vaccination behavior through the 5C model is to better understand the psychological underpinnings behind an individual’s vaccine behavior. Further investigation is required to determine the factors informing that state. Doing so can help tailor strategies designed to promote vaccine uptake to specific individual groups by targeting a specific factor.

The 5C model provides both a short and long validated scale for assessing the psychological antecedents of vaccination behavior.Citation15 While this model is available for adaptation and translation,Citation129 some non-English speaking, low-income countries have found it difficult to adapt the scale.Citation130

Use of the 5C model to promote vaccine uptake in non-pregnant individuals

Research using this model has explored the role of faith in one’s own intuition and the effects of decreasing complacency among target groups through the implementation of prosocial vaccination interventions.Citation131,Citation132 The 5C model has also been explored to understand the attitudes of physicians toward vaccination.Citation133 Physicians with positive attitudes toward vaccine mandates have been found to generally have higher levels of confidence and collective responsibility. Physicians’ own vaccination behavior was also found to be significantly related to their recommendation of vaccines, with high levels of confidence in vaccines being associated with active recommendation.Citation134 However, even within this group there were differences. Homeopathic physicians were found to have significantly lower confidence and higher complacency compared to other physicians, which influenced their vaccination recommendations.Citation134 A qualitative study of health-care workers across Europe also found that confidence largely contributed to vaccine recommendation behavior but also noted that confidence varied widely across nations.Citation135 The model has been applied to caregivers of children to assess willingness for vaccination against childhood diseases and Human Papilloma Virus in Malawi.Citation130 The study found that confidence in vaccine safety was the strongest predictor of routine childhood immunization, followed by constraints due to everyday stress.Citation130 In addition, a husband’s positive attitude increased childhood vaccination intention.Citation130 This points to the importance of identifying local determinants of vaccine hesitancy to develop successful programs.

Use of the 5C model in pregnant individuals

Little research has been done using the 5C model as a means to understand vaccine hesitancy in pregnant and lactating individuals. Two studies were done using this model in pregnancy.Citation136,Citation137 Using the 5C model in the pregnant population was a proposal for a vaccine hesitancy intervention in the pregnant population in India.Citation136 They propose administering the 5C scale at prenatal visits to identify individual patients’ unique behaviors and apply motivational interviewing techniques to address them in real time. However, the actual study has not yet been conducted. A study in Nigeria using the 5C model to understand drivers of vaccine hesitancy for themselves and their children concluded that the 5C model does not perform well in their population.Citation137 Their intention to vaccinate unborn children was lower if they were Muslims, had lower confidence in the public health system, if husband approval was important, and if they believed in rumor. The authors concluded that the 5C scale needs a revision before being widely used in Nigeria.Citation137

Use of the 5C model in COVID-19 vaccination uptake

The 5C model has been increasingly relevant in aiding our understanding of COVID-19 vaccine hesitancy. A technical report for the European Union on COVID-19 vaccine acceptance emphasized the importance of targeting different groups according to their specific needs in order to develop successful programs, using the 5C framework.Citation138 Research using the 5C model in COVID-19 vaccination behavior has consistently shown that high confidence and collective responsibility were associated with lower levels of vaccine hesitancy, as is seen with other vaccinations.Citation55,Citation138–148 However, differences within groups were also found. For instance, for Japanese men specifically, constraints were significantly associated with COVID-19 vaccine intention, suggesting that convenience may be an important factor in their vaccination decisions.Citation144 Additionally, a study of Israeli parents’ intent to vaccinate their children against COVID-19 found that in addition to higher confidence and collective responsibility, higher calculation was associated with vaccination intent.Citation140

A recent study of Health Care Workers found that attitudes toward the COVID-19 vaccine were distinct from other vaccines, in that one could be generally accepting of vaccines but hesitant about the COVID-19 vaccine specifically.Citation145

One study suggested using the 5C model to create profiles predicting COVID-19 vaccination intent and uptake to tailor interventions in nurses.Citation147 The most likely to vaccinate were ‘Believers’ (high confidence and collective responsibility, low complacency, and constraint) and Contradictors (high on all 5C measures). In the middle were ‘Middlers’ (moderate on all 5C measures) and Outsiders (Low calculation and collective responsibility). Least likely were ‘Skeptics’ (low confidence and collective responsibility, high complacency, and constraint).

Use of the 5C model in COVID-19 vaccination uptake in pregnant individuals

Up to this date, no studies were done examining the 5C model for COVID-19 vaccine acceptance among pregnant individuals.

Performance of the 5C model with annual vaccines versus vaccines given once or twice

The 5 C model has been applied to both annual and single-dose vaccines.Citation148,Citation149 A study on the vaccination behaviors of the elderly population in the UK used this model to compare annual influenza vaccine to single pneumonia and shingles vaccines and found that low confidence, low collective responsibility, and high constraint and complacency predicted low uptake of the influenza vaccine.Citation148 However, for the pneumonia and shingles vaccine, calculation was not a contributing factor in vaccine uptake. Another study looked specifically at the annual influenza vaccine among those with chronic respiratory conditions, finding that higher levels of collective responsibility and lower levels of constraints and complacency were associated with higher rates of vaccination.Citation149

5. The 5A model

The 5A model was proposed by Thompson and colleagues in 2016 includes five barriers and facilitators of vaccine update: Access – the ability of individuals to be reached by or to reach the recommended vaccines; Affordability – the ability of individuals to afford the vaccine both from financial and non-financial aspect (e.g., time); Awareness – the degree to which individuals have knowledge of the need for the vaccine and vaccine’s objective benefits and risks; Acceptance – the degree to which individuals accept, question, or refuse the vaccine; and Activation – the degree to which individuals are nudged toward vaccination uptake.Citation150

Use of the 5A model to promote vaccine uptake in non-pregnant individuals

A systematic review of vaccine uptake in the migrant population in Europe using the 5A model found multiple-access barriers to vaccination, including language, literary, and communication barriers.Citation151 Acceptance barriers were mostly reported in easter European and Muslim migrants for HPV, MMR, and influenza vaccines. Another recent review examined the 5A model for non-COVID-19 vaccine uptake within Roma communities across Europe.Citation152 In that study, access was identified as the greatest barrier to vaccination.

Use of the 5A model in pregnant individuals

Up-to-date, no studies were done examining the 5A model for vaccine acceptance among pregnant individuals.

Use of the 5A model in COVID-19 vaccination uptake

A mapping review of COVID-19 vaccine uptake among Adults 55 years and older in Africa with the 5A model taxonomy found that acceptance was the most commonly researched aspect of vaccine uptake (85%), followed by accessibility (25%), awareness (19%), and affordability (7%).Citation153 Activation was examined in only one study as a factor affecting COVID-19 vaccine acceptance. The review concluded that more studies are needed to evaluate the impact of nudges (activation) to improve COVID-19 vaccine uptake in African nations.

Use of the 5A model in COVID-19 vaccination uptake in pregnant individuals

Up-to-date, no studies were done examining the 5A model for COVID-19 vaccine acceptance among pregnant individuals.

Conclusion

The HBM, TPB, 3C model, 5C model, and 5A model have demonstrated great versatility in their ability to evaluate, explain, and modify vaccine hesitancy and behavior. While each of these models have demonstrated success, the HBM and 3C models are the most effective for assessing vaccination hesitancy within pregnant individuals. Overall, the HBM is the most utilized model to address vaccination hesitancy. The 3C model is also widely used and has demonstrated great efficacy and thoroughness in its ability to assess vaccination hesitancy. These models have repeatedly proven their ability to holistically explain and create change within vaccination behaviors.

Multiple studies have expressed concern about the TPB’s ability to predict vaccination behavior in pregnant individuals. The model has been criticized for not fully accounting for all variables that may contribute to vaccination behavior. Additionally, the model is more likely to predict vaccination intent rather than actual vaccination behavior. Finally, the TPB has not been utilized to assess COVID-19 vaccination promotion and uptake; rather, it has only been used to assess vaccination hesitancy.

While the 5C model can be used to assess the psychological antecedents of vaccination behavior, it is not as efficacious as the HBM and 3C models. Some non-English speaking, low-income countries have found it difficult to adapt the scale used in the model even though it is available for adaptation and translation. Moreover, being a new model, 5C’s use and effectiveness has not been well investigated in pregnant individual.

We conclude that the HBM and 3C models are the most effective tools to study and address vaccination hesitancy within the pregnant population. As demonstrated in the literature, there is a need for increased vaccination within pregnant individuals. This is particularly important with the COVID-19 vaccine and boosters. Principles and constructs of the HBM and 3C models may be combined to create the most effective tool for assessing vaccine hesitancy in pregnant individuals. This tool could be used to both further understand vaccine hesitancy and promote vaccination behaviors within pregnant patients for a multitude of vaccinations. Since the vaccine roll out in December 2020, we have robust, high-quality data on tens of thousands of pregnancies confirming vaccine safety and benefits in protecting the mothers and their unborn children from severe COVID-19 illness. Promoting this evidence-based information to increase vaccine confidence and perceived benefits through HBM or 3C model is important next step to decrease COVID-19 vaccine hesitancy.

Highlights

  • Health Belief and 3C models are effective to study vaccine hesitancy in pregnancy

  • These models could be combined to address COVID-19 vaccine acceptance in pregnancy

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

Dr. Palatnik is supported by the American Heart Association [Career Development award 847482].

References

  • COVID Data Tracker (CDC). Centers for Disease control and prevention. 2020 [accessed 2022 Apr 4]. https://covid.cdc.gov/covid-data-tracker/#vaccinations-pregnant-women.
  • Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, Roggero P, Prefumo F, Silva Do Vale M, Cardona-Perez JA, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study. JAMA Pediatr. 2021 Aug. [accessed 2021Dec 18];175(8):1–15. doi:10.1001/jamapediatrics.2021.1050.
  • Fu W, Sivajohan B, McClymont E, Albert A, Elwood C, Ogilvie G, Money D. Systematic review of the safety, immunogenicity, and effectiveness of COVID-19 vaccines in pregnant and lactating individuals and their infants. Int J Gynaecol Obstet. 2022 Mar;156(3):406–17. doi:10.1002/ijgo.14008.
  • Lipkind HS, Vazquez-Benitez G, DeSilva M, Vesco KK, Ackerman-Banks C, Zhu TG, Boyce TG, Daley MF, Fuller CC, Getahun D, et al. Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth - eight integrated health care organizations, December 15, 2020-July 22, 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan;71(1):26–30. doi:10.15585/mmwr.mm7101e1.
  • Morgan JA, Biggio JR Jr, Martin JK, Mussarat N, Chawla HK, Puri P, Williams FB. Maternal outcomes after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in vaccinated compared with unvaccinated pregnant patients. Obstet Gynecol. 2022 Jan;139(1):107–09. doi:10.1097/AOG.000000000000462.
  • Goldshtein I, Steinberg DM, KUint J, Chodick G, Segal Y, Shapiro S, David B, Ben-Tov A. Association of BNT162b2 COVID-19 vaccination during pregnancy with neonatal and early infant outcomes. JAMA Pediatr. 2022 May;176(5):470–77. doi:10.1001/jamapediatrics.2022.0001.
  • Halasa NB, Olson SM, Staat MA, Newhams MM, Price AM, Pannaraj PS, Boom JA, Sahni LC, Chiotos K, Cameron MA, et al. Maternal vaccination and risk of hospitalization for Covid-19 among infants. N Engl J Med. 2022 July;387(2):109–19. doi:10.1056/NEJMoa2204399.
  • Cases, data, and surveillance (CDC). Centers for Disease control and prevention. 2020 [accessed 2021 Dec 18]. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/special-populations/pregnancy-data-on-covid-19/what-cdc-is-doing.html.
  • Anachebe NF, Sutton MY. Racial disparities in reproductive health outcomes. Am J Obstet Gynecol. 2003 Apr [accessed 2021 Dec 19];188(4):S37–S42. doi:10.1067/mob.2003.245.
  • Stock SJ, Carruthers J, Calvert C, Denny C, Donaghy J, Goulding A, Hopcroft LEM, Hopkins L, McLaughlin T, Pan J, et al. SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland. Nat Med. 2022 Mar;28(3):504–12. doi:10.1038/s41591-021-01666-2.
  • Nachega JN, Sam-Agudu NA, Machekano RN, Rosenthal PJ, Schell S, de Waard L, Bekker A, Gachuno OW, Kinuthia J, Mwongeli N, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and pregnancy in Sub-Saharan Africa: a 6-country retrospective cohort analysis. Clin Infect Dis. 2022 Jun;8:294. doi:10.1093/cid/ciac294.
  • World Health Organization. Report of the SAGE working group on vaccine hesitancy. 2014. Accessed Feb 1, 2022 https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf.
  • Rosenstock I. Historical origins of the health belief model. Health Educ Monogr. 1974;2(4):328–35. doi:10.1177/109019817400200403.
  • Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179–211. doi:10.1016/0749-5978(91)90020-T.
  • Betsch C, Schmid P, Heinemeier D, Korn L, Holtmann C, Böhm R, Angelillo IF. Beyond confidence: development of a measure assessing the 5C psychological antecedents of vaccination. PLoS One. 2018 Dec [accessed 2021Nov 16];13(12):e0208601. doi:10.1371/journal.pone.0208601.
  • Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ Q. 1988;15(2):175–83. doi:10.1177/109019818801500203.
  • Botha E, van der Merwe D, Burnett RJ, Bester P. Predictors of parents’ infant vaccination decisions: a concept derivation. Health SA Gesondheid. 2021;26:1697.
  • Shahrabani S, Benzion U, Yom Din G. Factors affecting nurses’ decision to get the flu vaccine. Eur J Heal Econ HEPAC Heal Econ Prev Care. 2009 May;10(2):227–31. doi:10.1007/s10198-008-0124-3.
  • Brewer NT, Chapman GB, Gibbons FX, Gerrard M, McCaul KD, Weinstein ND. Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Heal Psychol Off J Div Heal Psychol Am Psychol Assoc. 2007 Mar;26(2):136–45.
  • Rosenstock IM. Why people use health services. Milbank Q. 2005;83(4). doi:10.3390/vaccines9050469.
  • Poon PKM, Zhou W, Chan DCC, Kwok KO, Wong SYS. Recommending COVID-19 vaccines to patients: practice and concerns of frontline family doctors. Vaccines. 2021 Nov;9(11):1319. doi:10.3390/vaccines9111319.
  • Okuyan B, Bektay MY, Demirci MY, Ay P, Sancar M. Factors associated with Turkish pharmacists’ intention to receive COVID-19 vaccine: an observational study. Int J Clin Pharm. 2021 Nov:1–9. doi:10.1007/s11096-020-01222-x.
  • Toth-Manikowski SM, Swirsky ES, Gandhi R, Piscitello G. COVID-19 vaccination hesitancy among health care workers, communication, and policy-making. Am J Infect Control. 2022 Jan;50(1):20–25. doi:10.1016/j.ajic.2021.10.004.
  • Spinewine A, Pétein C, Evrard P, Vastrade C, Laurent C, Delaere B, Henrard S . Attitudes towards COVID-19 vaccination among hospital staff-understanding what matters to hesitant people. Vaccines. 2021 May6;9(5):469. doi:10.3390/vaccines9050469.
  • Maraqa B, Nazzal Z, Rabi R, Sarhan N, Al-Shakhra K, Al-Kaila M. COVID-19 vaccine hesitancy among health care workers in Palestine: a call for action. Prev Med. 2021 Aug;149:106618. doi:10.1016/j.ypmed.2021.106618.
  • Al-Metwali BZ, Al-Jumaili AA, Al-Alag ZA, Sorofman B. Exploring the acceptance of COVID-19 vaccine among healthcare workers and general population using health belief model. J Eval Clin Pract. 2021 Oct;27(5):1112–22. doi:10.1111/jep.13581.
  • Yasuhara N, Okamoto S, Hamada M, Uehara K, Obana N, Imamura T. Evaluation of Japanese people’s perception of risk information for making decisions to receive influenza and rubella vaccinations. Heal Expect an Int J Public Particip Heal Care Heal Policy. 2021 Dec;24(6):2013–22.
  • Walker KK, Owens H, Zimet G. “We fear the unknown”: emergence, route and transfer of hesitancy and misinformation among HPV vaccine accepting mothers. Prev Med Rep. 2020 Dec;20:101240. doi:10.1016/j.pmedr.2020.101240.
  • Dyda A, King C, Dey A, Leask J, Dunn AG. A systematic review of studies that measure parental vaccine attitudes and beliefs in childhood vaccination. BMC Public Health. 2020 Aug;20(1):1253. doi:10.1186/s12889-020-09327-8.
  • Chang K, Lee SY. Why do some Korean parents hesitate to vaccinate their children? Epidemiol Health. 2019;41:e2019031. doi:10.4178/epih.e2019031.
  • Shapiro GK, Tatar O, Amsel R, Prue G, Zimet GD, Knauper B, Rosberger Z. Using an integrated conceptual framework to investigate parents’ HPV vaccine decision for their daughters and sons. Prev Med. 2018 Nov;116:203–10. doi:10.1016/j.ypmed.2018.09.017.
  • Deas J, Bean SJ, Sokolovska I, Fautin C. Childhood vaccine attitudes and information sources among Oregon parents and guardians. Health Promot Pract. 2019 Jul;20(4):529–38. doi:10.1177/1524839918778830.
  • Onyeneho N, Igwe I, I’Aronu N, Okoye U. Compliance with regimens of existing vaccines in Orumba North local government area of Anambra state, Nigeria. Int Q Community Health Educ. 2015;35(2):120–32. doi:10.1177/0272684X15569485.
  • Cmeciu C, Coman I. Governmental and public thematic patterns on vaccination during a measles outbreak: the Romanian perspective. Glob Health Promot. 2021 Sep;28(3):23–31. doi:10.1177/1757975920973000.
  • Bricout H, Torcel-Pagnon L, Lecomte C, Almas MF, Matthews I, Lu X, Wheelock A, Sevdalis N, Angelillo IF. Determinants of shingles vaccine acceptance in the United Kingdom. PLoS One. 2019;14(8):e0220230. doi:10.1371/journal.pone.0220230.
  • Hall CM, Northam H, Webster A, Strickland K. Determinants of seasonal influenza vaccination hesitancy among healthcare personnel: an integrative review. J Clin Nurs. 2022 Oct;31(15–16):2112–24. doi:10.1111/jocn.16103.
  • Mercadante AR, Law AV. Will they, or Won’t they? Examining patients’ vaccine intention for flu and COVID-19 using the Health Belief Model. Res Social Adm Pharm. 2021 Sep;17(9):1596–605. doi:10.1016/j.sapharm.2020.12.012.
  • Guidry JPD, Austin LL, O’Donnell NH, Coman IA, Lovari A, Messner M. Tweeting the #flushot: beliefs, barriers, and threats during different periods of the 2018 to 2019 flu Season. J Prim Care Community Health. 2020;11:2150132720932722. doi:10.1177/2150132720932722.
  • Goss MD, Temte JL, Barlow S, Temte E, Bell C, Birstler J, Chen G. An assessment of parental knowledge, attitudes, and beliefs regarding influenza vaccination. Vaccine. 2020 Feb;38(6):1565–71. doi:10.1016/j.vaccine.2019.11.040.
  • Trent MJ, Salmon DA, MacIntyre CR. Using the health belief model to identify barriers to seasonal influenza vaccination among Australian adults in 2019. Influenza Other Respi Viruses. 2021 Sep;15(5):678–87. doi:10.1111/irv.12843.
  • Du J, Luo C, Shegog R, Bian J, Cunningham RM, Boom JA, Poland GA, Chen Y, Tuo C. Use of deep learning to analyze social media discussions about the human papillomavirus vaccine. JAMA Netw open. 2020 Nov;3(11):e2022025. doi:10.1001/jamanetworkopen.2020.22025.
  • Luisi MLR. From bad to worse: the representation of the HPV vaccine Facebook. Vaccine. 2020 Jun;38(29):4564–73. doi:10.1016/j.vaccine.2020.05.016.
  • Restivo V, Costantino C, Fazio TF, Casuccio N, D’Angelo C, Vitale F, Casuccio A. Factors associated with HPV vaccine refusal among young adult women after ten years of vaccine implementation. Int J Environ Res Public Health. 2018 Apr;15(4). doi:10.3390/ijerph15040770.
  • Bronstein MV, Kummerfeld E, MacDonald A 3rd, Vinogradov S. Willingness to vaccinate against SARS-CoV-2: the role of reasoning biases and conspiracist ideation. Vaccine. 2022 Dec;40(2):213–22. doi:10.1016/j.vaccine.2021.11.079.
  • Bateman LB, Hall AG, Anderson WA, Cherrington AL, Helova A, Judd S, Kimberly R, Oates GR, Osborne T, Ott C, et al. Exploring COVID-19 vaccine hesitancy among stakeholders in African American and Latinx communities in the deep south through the lens of the Health Belief Model. Am J Health Promot. 2022 Feb;36(2):288–295.
  • Badr H, Zhang X, Oluyomi A, Woodard LD, Adepoju OE, Raza SA, Amos CI. Overcoming COVID-19 vaccine hesitancy: insights from an online population-based survey in the United States. Vaccines. 2021 Sep;9(10):1100. doi:10.3390/vaccines9101100.
  • Wang R, Tao L, Han N, Liu J, Yuan C, Deng L, Han C, Sun F, Chi L, Liu M, et al. Acceptance of seasonal influenza vaccination and associated factors among pregnant women in the context of COVID-19 pandemic in China: a multi-center cross-sectional study based on health belief model. BMC Pregnancy Childbirth. 2021 Nov;21(1):745. doi:10.1186/s12884-021-04224-3.
  • Tao L, Wang R, Han N, Liu J, Yuan C, Deng L, Han C, Sun F, Liu M, Liu J. Acceptance of a COVID-19 vaccine and associated factors among pregnant women in China: a multi-center cross-sectional study based on health belief model. Hum Vaccin Immunother. 2021 Aug;17(8):2378–88. doi:10.1080/21645515.2021.1892432.
  • Yuen CYS, Dodgson JE, Tarrant M. Perceptions of Hong Kong Chinese women toward influenza vaccination during pregnancy. Vaccine. 2016 Jan;34(1):33–40. doi:10.1016/j.vaccine.2015.11.032.
  • Du M, Tao L, Liu J. The association between risk perception and COVID-19 vaccine hesitancy for children among reproductive women in China: an online survey. Front Med. 2021;8:741298. doi:10.3389/fmed.2021.741298.
  • Chen H, Li X, Gao J, Liu X, Mao Y, Wang R, Zheng P, Xiao Q, Jia Y, Hua F, et al. Health Belief Model perspective on the control of COVID-19 vaccine hesitancy and the promotion of vaccination in China: web-based cross-sectional study. J Med Internet Res. 2021 Sep;23(9):e29329. doi:10.2196/29329.
  • Yan E, Lai DWL, Lee VWP. Predictors of intention to vaccinate against COVID-19 in the general public in Hong Kong: findings from a population-Based, cross-sectional survey. Vaccines. 2021 Jun;9(7):696. doi:10.3390/vaccines9070696.
  • Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLoS Negl Trop Dis. 2020 Dec;14(12):e0008961. doi:10.1371/journal.pntd.0008961.
  • Patwary MM, Bardhan M, Disha AS, Hasan M, Haque MZ, Sultana R, Hossain MR, Browning M, Alam MA, Sallam M. Determinants of COVID-19 vaccine acceptance among the adult population of Bangladesh using the Health belief model and the theory of planned behavior model. Vaccines. 2021 Nov;9(12):12. doi:10.3390/vaccines9121393.
  • Hossain MB, Alam MZ, Islam MS, Sultan S, Faysal MM, Rima S, Hossain MA, Mamun AA. Health Belief Model, theory of planned behavior, or psychological antecedents: what predicts COVID-19 vaccine hesitancy better among the Bangladeshi adults? Front Public Health. 2021;9:711066. doi:10.3389/fpubh.2021.711066.
  • Kalam MA, Davis TPJ, Shano S, Uddin MN, Islam MA, Kanwagi R, Islam A, Hassan MM, Larson HJ, Metwally AM. Exploring the behavioral determinants of COVID-19 vaccine acceptance among an urban population in Bangladesh: implications for behavior change interventions. PLoS One. 2021;16(8):e0256496. doi:10.1371/journal.pone.0256496.
  • Le An P, Nguyen HTN, Nguyen DD, Vo LY, Huynh G. The intention to get a COVID-19 vaccine among the students of health science in Vietnam. Hum Vaccin Immunother. 2021 Dec 2;17(12): 4823–482.
  • Guillon M, Kergall P. Factors associated with COVID-19 vaccination intentions and attitudes in France. Public Health. 2021 Sep;198:200–07. doi:10.1016/j.puhe.2021.07.035.
  • Mahmud I, Kabir R, Rahman MA, Alradie-Mohamed A, Vinnakota D, Al-Mohaimeed A. The Health Belief Model predicts intention to receive the COVID-19 vaccine in Saudi Arabia: results from a cross-sectional survey. Vaccines. 2021 Aug;9(8):864. doi:10.3390/vaccines9080864.
  • Jin Q, Raza SH, Yousaf M, Zaman U, Siang JMLD. Can communication strategies combat COVID-19 vaccine hesitancy with trade-off between public service messages and public skepticism? Experimental evidence from Pakistan. Vaccines. 2021 Jul;9(7):757. doi:10.3390/vaccines9070757.
  • Tao L, Wang R, Liu J. Comparison of vaccine acceptance between COVID-19 and seasonal influenza among women in China: a national online survey based on Health Belief Model. Front Med. 2021;8:679520. doi:10.3389/fmed.2021.679520.
  • Zambri F, Perilli I, Quattrini A, Marchetti F, Colaceci S, Giusti A. Health Belief Model efficacy in explaining and predicting intention or uptake pertussis vaccination during pregnancy. Ann Ist Super Sanita. 2021;57(2):167–73. doi:10.4415/ANN_21_02_09.
  • Natan MB, El Kravchenko B, Sakashidlo K, Mor S. What drives pregnant women’s decisions to accept the pertussis vaccine? Appl Nurs Res. 2017 Dec;38:60–63. doi:10.1016/j.apnr.2017.09.013.
  • Hayles EH, Cooper SC, Sinn J, Wood N, Leask J, Skinner SR. Pertussis vaccination coverage among Australian women prior to childbirth in the cocooning era: a two-hospital, cross-sectional survey, 2010 to 2013. Aust N Z J Obstet Gynaecol. 2016 Apr;56(2):185–91. doi:10.1111/ajo.12429.
  • Payakachat N, Hadden KB, Ragland D. Promoting Tdap immunization in pregnancy: associations between maternal perceptions and vaccination rates. Vaccine. 2016 Jan;34(1):179–86. doi:10.1016/j.vaccine.2015.09.062.
  • Nankya-Mutyoba J, Aizire J, Makumbi F, Ocama P, Kirk GD. Hepatitis B virus perceptions and health seeking behaviors among pregnant women in Uganda: implications for prevention and policy. BMC Health Serv Res. 2019 Oct;19(1):760. doi:10.1186/s12913-019-4516-0.
  • Wong LP, Alias H, Hassan J, AbuBakar S. Attitudes towards Zika screening and vaccination acceptability among pregnant women in Malaysia. Vaccine. 2017 Oct;35(43):5912–17. doi:10.1016/j.vaccine.2017.08.074.
  • Dempsey AF, Brewer SE, Sevick C, Pyrzanowski J, Mazzoni S, O’Leary ST. Tdap vaccine attitudes and utilization among pregnant women from a high-risk population. Hum Vaccin Immunother. 2016 Apr;12(4):872–78. doi:10.1080/21645515.2015.1094594.
  • Fridman D, Steinberg E, Azhar E, Weedon J, Wilson TE, Minkoff H. Predictors of H1N1 vaccination in pregnancy. Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S124–7. doi:10.1016/j.ajog.2011.04.011.
  • Fabry P, Gagneur A, Pasquier J-C. Determinants of A (H1N1) vaccination: cross-sectional study in a population of pregnant women in Quebec. Vaccine. 2011 Feb;29(9):1824–29. doi:10.1016/j.vaccine.2010.12.109.
  • Myers KL. Predictors of maternal vaccination in the United States: an integrative review of the literature. Vaccine. 2016 Jul;34(34):3942–49. doi:10.1016/j.vaccine.2016.06.042.
  • Hawlader MDH, Rahman ML, Nazir A, Ara T, Haque MMA, Saha S, Barsha SY, Hossian M, Matin KF, Siddiquea SR, et al. COVID-19 vaccine acceptance in South Asia: a multi-country study. Int J Infect Dis. 2021 Sep;114:1–10.
  • Jiang T, Zhou X, Wang H, Dong S, Wang M, Akezhuoli H, Zhu H. COVID-19 vaccination intention and influencing factors among different occupational risk groups: a cross-sectional study. Hum Vaccin Immunother. 2021 Oct;17(10):3433–40. doi:10.1080/21645515.2021.1930473.
  • Walker KK, Head KJ, Owens H, Zimet GD. A qualitative study exploring the relationship between mothers’ vaccine hesitancy and health beliefs with COVID-19 vaccination intention and prevention during the early pandemic months. Hum Vaccin Immunother. 2021 Oct;17(10):3355–64. doi:10.1080/21645515.2021.1942713.
  • Firouzbakht M, Sharif NH, Kazeminavaei F, Rashidian P. Hesitancy about COVID-19 vaccination among pregnant women: a cross-sectional study based on the health belief model. BMC Pregnancy Childbirth. 2022 Aug;2(1):611. doi:10.1186/s12884-022-04941-3.
  • Greyson D, Dubé È, Fisher WA, Cook J, Sadarangani M, Bettinger JA. Understanding influenza vaccination during pregnancy in Canada: attitudes, norms, intentions, and vaccine uptake. Health Educ Behav. 2021 Oct;48(5):680–89.
  • Ajzen I. Attitudes, personality, and behavior. Chicago (IL): Dorsey Press; 1988.
  • Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D, Yaseen A, Ababneh NA, Bakri FG, Mahafzah A. High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: a study in Jordan and Kuwait among other Arab countries. Vaccines. 2021 Jan;9(1):42. doi:10.3390/vaccines9010042.
  • Guidry JPD, Laestadius LI, Vraga EK, Miller CA, Perrin PB, Burton CW, Ryan M, Fuemmeler BF, Carlyle KE. Willingness to get the COVID-19 vaccine with and without emergency use authorization. Am J Infect Control. 2021 Feb;49(2):137–42. doi:10.1016/j.ajic.2020.11.018.
  • Fishbein M, Ajzen I. Predicting and changing behavior: the reasoned action approach. New York (NY): Psychology Press; 2010.
  • Armitage CJ, Conner M. Efficacy of the theory of planned behaviour: a meta-analytic review. Br J Soc Psychol. 2001 Dec;40(Pt 4):471–99. doi:10.1348/014466601164939.
  • Caso D, Capasso M, Fabbricatore R, Conner M. Understanding the psychosocial determinants of Italian parents’ intentions not to vaccinate their children: an extended theory of planned behaviour model. Psychol Health. 2022 Sep;37(9):1111–1131.
  • Hu Y, Chen Y, Wang Y, Liang H. Measuring childhood vaccination acceptance of mother in Zhejiang province, East China. Hum Vaccin Immunother. 2019;15(2):287–94. doi:10.1080/21645515.2018.1526557.
  • Dubé E, Gagnon D, Ouakki M, Bettinger JA, Witteman HO, MacDonald S, Fisher W, Saini V, Greyson D. Canadian immunization research network. measuring vaccine acceptance among Canadian parents: a survey of the Canadian immunization research network. Vaccine. 2018 Jan;36(4):545–52. doi:10.1016/j.vaccine.2017.12.005.
  • Wheeler M, Buttenheim AM. Parental vaccine concerns, information source, and choice of alternative immunization schedules. Hum Vaccin Immunother. 2013 Aug;9(8):1782–89. doi:10.4161/hv.25959.
  • Falope O, Vamos C, Izurieta R, Daley E, Kirby RS. The knowledge and perceptions of Florida pharmacists in administering inactivated influenza vaccines to pregnant women. Pharmacy (Basel). 2021 Apr 16;9(2):83.doi:10.3390/pharmacy9020083.
  • Chu A, Gupta V, Unni EJ. Utilizing the theory of planned behavior to determine the intentions to receive the influenza vaccine during COVID-19: a cross-sectional survey of US adults. Prev Med Rep. 2021 Sep;23:101417. doi:10.1016/j.pmedr.2021.101417.
  • Schmid P, Rauber D, Betsch C, Lidolt G, Denker M-L. Barriers of influenza vaccination intention and behavior: a systematic review of influenza vaccine hesitancy, 2005-2016. PLoS One. 2017;12(1):e0170550. doi:10.1371/journal.pone.0170550.
  • Shah SFA, Ginossar T, Bentley JM, Zimet G, McGrail JP. Using the theory of planned behavior to identify correlates of HPV vaccination uptake among college students attending a rural university in Alabama. Vaccine. 2021 Dec;39(51):7421–28. doi:10.1016/j.vaccine.2021.10.082.
  • Myers LB, Goodwin R. Using a theoretical framework to determine adults’ intention to vaccinate against pandemic swine flu in priority groups in the UK. Public Health. 2012 Sep;126(Suppl):S53–6. doi:10.1016/j.puhe.2012.05.024.
  • Ryan M, Marlow LAV, Forster A. Countering vaccine hesitancy among pregnant women in England: the case of Boostrix-IPV. Int J Environ Res Public Health. 2020 Jul;17(14):4984. doi:10.3390/ijerph17144984.
  • Rountree C, Prentice G. Segmentation of intentions towards COVID-19 vaccine acceptance through political and health behaviour explanatory models. Ir J Med Sci. 2022 Oct;191(5):2369–2383.
  • Breslin G, Dempster M, Berry E, Cavanagh M, Armstrong NC, Gesser-Edelsburg A. COVID-19 vaccine uptake and hesitancy survey in Northern Ireland and Republic of Ireland: applying the theory of planned behaviour. PLoS One. 2021;16(11):e0259381. doi:10.1371/journal.pone.0259381.
  • Thaker J, Ganchoudhuri S. The role of attitudes, norms, and efficacy on shifting COVID-19 Vaccine Intentions: a longitudinal study of COVID-19 vaccination intentions in New Zealand. Vaccines. 2021 Oct;9(10):1132. doi:10.3390/vaccines9101132.
  • Al-Wutayd O, Khalil R, Rajar AB. Sociodemographic and behavioral predictors of COVID-19 vaccine hesitancy in Pakistan. J Multidiscip Healthc. 2021;22:2847–56. doi:10.2147/JMDH.S325529.
  • Cordina M, Lauri MA, Lauri J. Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine. Pharm Pract (Granada). 2021;19(1):2317. doi:10.18549/PharmPract.2021.1.2317.
  • Winter K, Pummerer L, Hornsey MJ, Sassenberg K. Pro-vaccination subjective norms moderate the relationship between conspiracy mentality and vaccination intentions. Br J Health Psychol. 2021 Jul. doi:10.1111/bjhp.12550.
  • Wermers R, Ostroski T, Hagler D. Health care provider use of motivational interviewing to address vaccine hesitancy in college students. J Am Assoc Nurse Pract. 2021 Jan;33(1):86–93. doi:10.1097/JXX.0000000000000281.
  • Larson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine. 2014 Apr;32(19):2150–59. doi:10.1016/j.vaccine.2014.01.081.
  • Dubé E, Gagnon D, Nickels E, Jeram S, Schuster M. Mapping vaccine hesitancy—Country-specific characteristics of a global phenomenon. Vaccine. 2014 Nov. [accessed 2021 Dec 18];32(49).6649–54. https://www.sciencedirect.com/science/article/pii/S0264410X14013073.
  • MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015 Aug [accessed 2021 Nov 8];33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.
  • Decouttere C, Banzimana S, Davidsen P, Van Riet C, Vandermeulen C, Mason E, Jalali MS, Vandaele N. Insights into vaccine hesitancy from systems thinking, Rwanda. Bull World Health Organ. 2021 Nov [accessed 2022 Apr 4];99(11):783–94. doi:10.2471/BLT.20.285258.
  • Sabahelzain MM, Moukhyer M, Bosma H, van den Borne B. Determinants of measles vaccine hesitancy among Sudanese parents in Khartoum State, Sudan: a cross-sectional study. Vaccines. 2021 Dec [Accessed 2022 Apr 4];10(1):6. doi:10.3390/vaccines10010006.
  • Siani A, Driscoll M, Hurst T, Coker T, Grantham AG, Bunet A. Investigating the determinants of vaccine hesitancy within undergraduate students’ social sphere. J Public Health (Bangkok). 2021 Apr. [accessed 2022 Apr 4]. doi:10.1007/s10389-021-01538-6.
  • Moretti F, Visentin D, Bovolenta E, Rimondini M, Majori S, Mazzi M, Poli A, Tardivo S, Torri E. Attitudes of nursing home staff towards influenza vaccination: opinions and factors influencing hesitancy. Int J Environ Res Public Health. 2020 Mar [accessed 2022 Apr 4];17(6):1851. doi:10.3390/ijerph17061851.
  • Lau LHW, Lee SS, Wong NS. The continuum of influenza vaccine hesitancy among nursing professionals in Hong Kong. Vaccine. 2020 Oct [accessed 2022 Apr 4];38(43):6785–93. doi:10.1016/j.vaccine.2020.08.038.
  • Zhou L, Wang J, Cheng P, Li Y, Liu G, Zhang X. HPV vaccine hesitancy among medical students in China: a multicenter survey. Front Public Heal. 2022 Feb. [accessed 2022 Apr 4];10:774767. https://www.frontiersin.org/articles/10.3389/fpubh.2022.774767/full.
  • Klassen AC, Milliron BJ, Reynolds L, Bakhtibekova Z, Mamadraimov S, Bahruddinov M, Shokamolova S, Shuster M, Mukhtar S, Gafurova M, et al. Formative research to address vaccine hesitancy in Tajikistan. Vaccine. 2021 Mar;39(10):1516–27. doi:10.1016/j.vaccine.2021.01.033.
  • Gianfredi V, Moretti M, Lopalco PL. Countering vaccine hesitancy through immunization information systems, a narrative review. Hum Vaccin Immunother. 2019 Nov. [accessed 2022 Apr 4];15(11):2508–26. https://www.tandfonline.com/doi/full/10.1080/21645515.2019.1599675.
  • Taddio A, MacDonald N. Addressing vaccine hesitancy in travellers: the CARDTM system. J Travel Med. 2019;26(6). doi:10.1093/jtm/taz056.
  • Verger P, Botelho-Nevers E, Garrison A, Gagnon D, Gagneur A, Gagneux-Brunon A, Dubé E. Vaccine hesitancy in health-care providers in Western countries: a narrative review. Expert Rev Vaccines. 2022 Mar. [accessed 2022 Apr 4]:1–19. https://www.tandfonline.com/doi/full/10.1080/14760584.2022.2056026.
  • Rosso A, Massimi A, Pitini E, Nardi A, Baccolini V, Marzuillo C, De Vito C, Villari P. Factors affecting the vaccination choices of pregnant women for their children: a systematic review of the literature. Hum Vaccin Immunother. 2020 Aug. [accessed 2022 Apr 4];16(8):1969–80. https://www.tandfonline.com/doi/full/10.1080/21645515.2019.1698901.
  • Wilson RJ, Paterson P, Jarrett C, Larson HJ. Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review. Vaccine. 2015 Nov;33(47):6420–29. doi:10.1016/j.vaccine.2015.08.046.
  • González-Block MÁ, Pelcastre-Villafuerte BE, Knauth DR, Fachel-Leal A, Comes Y, Crocco P, Noboa L, Rodríguez Zea BR, Ruoti M, Díaz-Portillo SP, et al. Influenza vaccination hesitancy in large urban centers in South America. Qualitative analysis of confidence, complacency and convenience across risk groups. PLoS One. 2021 Aug. [accessed 2021 Dec 20];16(8):e0256040. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0256040.
  • Mutyoba JN, Surkan PJ, Makumbi F, Aizire J, Kirk GD, Ocama P, Atuyambe LM. Hepatitis B birth dose vaccination for newborns in Uganda: a qualitative inquiry on pregnant women’s perceptions, barriers and preferences. J Virus Erad. 2021 Jun [accessed 2022 Apr 4];7(2):100039. doi:10.1016/j.jve.2021.100039.
  • Wang J, Ji Q, Dong S, Zhao S, Li X, Zhu Q, Long S, Zhang J, Jin H. Factors influencing vaccine hesitancy in China: a qualitative study. Vaccines. 2021 Nov [accessed 2022 Apr 4];9(11):1291. doi:10.3390/vaccines9111291.
  • Gerretsen P, Kim J, Caravaggio F, Quilty L, Sanches M, Wells S, Brown EE, Agic B, Pollock BG, Graff-Guerrero A. Individual determinants of COVID-19 vaccine hesitancy. PLoS One. 2021 Nov [accessed 2022 Apr 4];16(11):e0258462. doi:10.1371/journal.pone.0258462.
  • Chan NN, Ong KW, Siau CS, Lee KW, Peh SC, Yacob S, Chia YC, Seow VK, Ooi PB. The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal. BMC Public Health. 2022 Dec [accessed 2022 Apr 4];22(1):296. doi:10.1186/s12889-022-12632-z.
  • Luk TT, Zhao S, Wu Y, Wong JY, Wang MP, Lam TH. Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: a population-based survey. Vaccine. 2021 Jun [accessed 2022 Apr 4];39(27):3602–07. doi:10.1016/j.vaccine.2021.05.036.
  • Liu X, Dai J, Chen H, Li X, Chen S, Yu Y, Zhao Q, Wang R, Mao Y, Fu H, et al. Factors related to public COVID-19 vaccine hesitancy based on the 3C model: a cross-sectional study. Fudan Univ J Med Sci. 2021;48:307–12. http://jms.fudan.edu.cn.
  • Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021 Apr [accessed 2021 Dec 20];6(4):e210–e221. doi:10.1016/S2468-2667(21)00012-8.
  • Turhan Z, Dilcen HY, Dolu İ. The mediating role of health literacy on the relationship between health care system distrust and vaccine hesitancy during COVID-19 pandemic. Curr Psychol. 2022 Jul. [accessed 2021 Dec 20]; 41(11):8147–56. doi:10.1007/s12144-021-02105-8.
  • Liu R, Li GM. Hesitancy in the time of coronavirus: temporal, spatial, and sociodemographic variations in COVID-19 vaccine hesitancy. SSM Popul Health. 2021 Sep. [accessed 2022 Apr 4];15:100896. doi:10.1016/j.ssmph.2021.100896.
  • Skirrow H, Barnett S, Bell S, Riaposova L, Mounier-Jack S, Kampmann B, Holder B. Women’s views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK. BMC Pregnancy Childbirth. 2022 Jan;22(1):33. doi:10.1186/s12884-021-04321-3.
  • Cui Y, Binger K, Palatnik A. Attitudes and beliefs associated with COVID-19 vaccination during pregnancy. JAMA Netw open. 2022 Apr;5(4):e227430. doi:10.1001/jamanetworkopen.2022.7430.
  • Quinn SC, Jamison AM, An J, Hancock GR, Freimuth VS. Measuring vaccine hesitancy, confidence, trust and flu vaccine uptake: results of a national survey of White and African American adults. Vaccine. 2019 Feb [accessed 2021 Nov 16];37(9):1168–73. doi:10.1016/j.vaccine.2019.01.033.
  • Turner PJ, Larson H, Dubé È, Fisher A. Vaccine hesitancy: drivers and how the allergy community can help. J Allergy Clin Immunol Pract. 2021 Oct;9(10):3568–74. doi:10.1016/j.jaip.2021.06.035.
  • Betsch C, Böhm R, Chapman GB. Using behavioral insights to increase vaccination policy effectiveness. Policy Insights Behav Brain Sci. 2015 Oct. [accessed 2021 Dec 18]; 2(1):61–73. doi:10.1177/2372732215600716.
  • Betsch C, Bach Habersaat K, Deshevoi S, Heinemeier D, Briko N, Kostenko N, Kocik J, Böhm R, Zettler I, Wiysonge CS, et al. Sample study protocol for adapting and translating the 5C scale to assess the psychological antecedents of vaccination. BMJ Open. 2020 Mar. [accessed 2022 Apr 4];10(3):e034869. doi:10.1136/bmjopen-2019-034869.
  • Adeyanju GC, Sprengholz P, Betsch C, Essoh T-A. Caregivers’ willingness to vaccinate their children against childhood diseases and human papillomavirus: a cross-sectional study on vaccine hesitancy in Malawi. Vaccines. 2021 Oct [accessed 2022 Apr 4];9(11):1231. doi:10.3390/vaccines9111231.
  • Schindler J, Schindler S, Pfattheicher S. The role of intuition in vaccination attitudes. J Health Psychol. 2021 Dec. [accessed 2021 Dec 20]; 26(14):2950–57. doi:10.1177/1359105320925160.
  • Böhm R, Betsch C. Prosocial vaccination. Curr Opin Psychol. 2022 Feb. [accessed 2021 Dec 20];43:307–11. doi:10.1016/j.copsyc.2021.08.010.
  • Neufeind J, Betsch C, Zylka-Menhorn V, Wichmann O. Determinants of physician attitudes towards the new selective measles vaccine mandate in Germany. BMC Public Health. 2021 Mar;21(1):566. doi:10.1186/s12889-021-10563-9.
  • Neufeind J, Betsch C, Habersaat KB, Eckardt M, Schmid P, Wichmann O. Barriers and drivers to adult vaccination among family physicians – insights for tailoring the immunization program in Germany. Vaccine. 2020 Jun [cited 2021 Dec 21];38(27):4252–62. doi:10.1016/j.vaccine.2020.04.052.
  • Karafillakis E, Dinca I, Apfel F, Cecconi S, Wűrz A, Takacs J, Suk J, Celetano LP, Kramarz P, Larson HJ. Vaccine hesitancy among healthcare workers in Europe: a qualitative study. Vaccine. 2016 Sep [accessed 2021 Dec 21];34(41):5013–20. doi:10.1016/j.vaccine.2016.08.029.
  • Ransing R, Kukreti P, Raghuveer P, Puri M, Paranjape AD, Patil S, Hegde P, Padma K, Kumar P, Kishore J, et al. A brief psycho-social intervention for COVID-19 vaccine hesitancy among perinatal women in low-and middle-income countries: need of the hour. Asian J Psychiatr. 2022 Jan. [accessed 2021 Dec 19];67:102929. doi:10.1016/j.ajp.2021.102929.
  • Adeyanju GC, Sprengholz P, Betsch C. Understanding drivers of vaccine hesitancy among pregnant women in Nigeria: a longitudinal study. NPJ Vaccines. 2021 Mar;7(1):96. doi:10.1038/s41541-022-00489-7.
  • Nath R, Imtiaz A, Nath SD, Hasan E. Role of vaccine hesitancy, eHealth literacy, and vaccine literacy in young adults’ COVID-19 vaccine uptake intention in a lower-middle-income country. Vaccines. 2021 Nov [accessed 2022 Apr 4];9(12):1405. doi:10.3390/vaccines9121405.
  • Barello S, Palamenghi L, Graffigna G. Looking inside the ‘black box’ of vaccine hesitancy: unlocking the effect of psychological attitudes and beliefs on COVID-19 vaccine acceptance and implications for public health communication. Psychol Med. 2021 Mar. [accessed 2022 Apr 4]:1–2. doi:10.1017/S003329172100101X.
  • Gendler Y, Ofri L. Investigating the influence of vaccine literacy, vaccine perception and vaccine hesitancy on Israeli parents’ acceptance of the COVID-19 vaccine for their children: a cross-sectional study. Vaccines. 2021 Nov [accessed 2022 Apr 4];9(12):1391. doi:10.3390/vaccines9121391.
  • Hwang SE, Kim W-H, Heo J. Socio-demographic, psychological, and experiential predictors of COVID-19 vaccine hesitancy in South Korea, October-December 2020. Hum Vaccin Immunother. 2021 Oct. [accessed 2021 Dec 21]:1–8. doi:10.1080/21645515.2021.1983389.
  • Kwok KO, Li -K-K, Wei WI, Tang A, Wong SYS, Lee SS. Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: a survey. Int J Nurs Stud. 2021 Feb. [accessed 2021 Dec 20];114:103854. doi:10.1016/j.ijnurstu.2020.103854.
  • Machida M, Nakamura I, Kojima T, Saito R, Nakaya T, Hanibuchi T, Takamiya T, Odagiri Y, Fukusima N, Kikuchi H, et al. Acceptance of a COVID-19 vaccine in Japan during the COVID-19 pandemic. Vaccines. 2021 Mar. [accessed 2021 Dec 20];9(3):210. doi:10.3390/vaccines9030210.
  • Machida M, Nakamura I, Kojima T, Saito R, Nakaya T, Hanibuchi T, Takamiya T, Odagiri Y, Fukushima N, Kikuchi H, et al. Trends in COVID-19 vaccination intent from pre- to post-COVID-19 vaccine distribution and their associations with the 5C psychological antecedents of vaccination by sex and age in Japan. Hum Vaccin Immunother. 2021 Nov:1–9. doi:10.1080/21645515.2021.1968217.
  • Navin MC, Oberleitner LM-S, Lucia VC, Ozdych M, Afonso N, Kennedy RH, Keil H, Wu L, Matthew TA. COVID-19 vaccine hesitancy among healthcare personnel who generally accept vaccines. J Community Health. 2022 Mar. [accessed 2022 Apr 4]. https://link.springer.com/10.1007/s10900-022-01080-w.
  • Wismans A, Thurik R, Baptista R, Dejardin M, Janssen F, Franken I, Delcea C. Psychological characteristics and the mediating role of the 5C Model in explaining students’ COVID-19 vaccination intention. PLoS One. 2021 Aug [accessed 2022 Apr 4];16(8):e0255382. doi:10.1371/journal.pone.0255382.
  • Leung CLK, Li -K-K, Wei VWI, Tang A, Wong SYS, Lee SS, Kwok KO. Profiling vaccine believers and skeptics in nurses: a latent profile analysis. Int J Nurs Stud. 2022 Feb. [accessed 2022 Apr 4];126:104142. doi:10.1016/j.ijnurstu.2021.104142.
  • Nicholls LAB, Gallant AJ, Cogan N, Rasmussen S, Young D, Williams L. Older adults’ vaccine hesitancy: psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake. Vaccine. 2021 Jun;39(26):3520–27. doi:10.1016/j.vaccine.2021.04.062.
  • Williams L, Deakin K, Gallant A, Rasmussen S, Young D, Cogan N. A mixed methods study of seasonal influenza vaccine hesitancy in adults with chronic respiratory conditions. Influenza Other Respi Viruses. 2021 Sep [accessed 2022 Apr 4];15(5):625–33. doi:10.1111/irv.12856.
  • Thomson A, Robinson K, Vallée-Tourangeau G. The 5As: a practical taxonomy for the determinants of vaccine uptake. Vaccine. 2016 Feb;34(8):1018–24. doi:10.1016/j.vaccine.2015.11.065.
  • Crawshaw AF, Farah Y, Deal A, Rustage K, Hayward SE, Carter J, Knights F, Goldsmith LP, Campos-Matos I, Wurie F, et al. Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review. Lancet Infect Dis. 2022 Sept;22(9):e254–266. doi:10.1016/s1473-3099(22)00066-4.
  • Cronin A, Ibrahimm N. A scoping review of literature exploring factors affecting vaccine uptake within Roma communities across Europe. Expert Rev Vaccines. 2022 Aug;1:1–14. doi:10.1080/14760584.2022.2104715.
  • Kalu ME, Oyinlola O, Ibekaku MC, Adandom II, Iwuagwu AO, Ezulike CJ, Nwachukwu EC, Uduonu E. A mapping review on the uptake of the COVID-19 Vaccine among adults in Africa using the 5A’s vaccine taxonomy. Am J Trop Med Hyg. 2022 May 6;6:1688–97. doi:10.4269/ajtmh.21-0515.